BioSpace News Archive

Press Releases

C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO®) for Relapsed/Refractory Multiple Myeloma

March 25, 2026
·
8 min read
Press Releases

Cellbricks Therapeutics Raises €10 Million New Capital to Move Living Tissue Implants Toward the Clinic

March 25, 2026
·
5 min read
Press Releases

Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite

March 25, 2026
·
3 min read
Press Releases

NetraMark Announces Strategic Oncology Research Collaboration with Fondazione per la Medicina Personalizzata to Analyze Landmark ROME Trial Dataset

March 25, 2026
·
8 min read
Press Releases

Biolojic Design Earns Preclinical Milestone from Teva for First AI-Designed Multibody in Autoimmune Disease, TEV ‘325 (formerly BD9)

March 25, 2026
·
2 min read
Press Releases

Endogenex Closes $50 Million Series C Extension to Fund Pivotal Clinical Study and Path to FDA Approval

March 25, 2026
·
4 min read
Press Releases

Picard Medical Reports Full Year 2025 Financial Results

March 25, 2026
·
5 min read
Press Releases

Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.

March 25, 2026
·
3 min read
Press Releases

Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease

March 25, 2026
·
8 min read
Press Releases

Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights

March 25, 2026
·
11 min read